Management of hypersensitivity reactions to Tocilizumab

Clin Exp Allergy. 2018 Jun;48(6):749-752. doi: 10.1111/cea.13142. Epub 2018 May 1.

Authors

P Tétu¹, A Hamelin¹, P Moguelet², A Barbaud^{1

3}, A Soria^{1

3

4}

Affiliations

¹ APHP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France.
² APHP, Service d'Anatomopathologie, Hôpital Tenon, Paris, France.
³ Faculté de Médecine Sorbonne Université, Sorbonne Université, Paris, France.
⁴ Centre d'Immunologie et des Maladies Infectieuses (Cimi-Paris), Paris, France.

PMID: 29603809
DOI: 10.1111/cea.13142

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects*
Biopsy
Disease Management
Drug Hypersensitivity / diagnosis*
Drug Hypersensitivity / therapy*
Humans
Immunoglobulin E / blood
Immunoglobulin E / immunology
Severity of Illness Index
Skin Tests

Substances

Antibodies, Monoclonal, Humanized
Immunoglobulin E
tocilizumab